DSV launches Incheon hub to strengthen worldwide healthcare supply chains.

Global biomanufacturing is shifting towards East Asia, with South Korea becoming a leader in contract manufacturing and biosimilar production. To enhance the cold-chain logistics for high-value biological products, DSV has established a specialized Air ThermoDirect facility at Incheon International Airport. This facility ensures temperature-controlled transport, crucial for the safe delivery of biopharmaceuticals, by featuring dedicated storage and real-time tracking. As South Korea expands its biomanufacturing, the logistics infrastructure must adapt, making robust cold chains essential for competitiveness in the life sciences sector.